20 research outputs found
Treatment of American tegumentary leishmaniasis in special populations : a summary of evidence
We aimed to assess and synthesize the information available in the literature regarding the treatment of American tegumentary leishmaniasis in special populations. We searched MEDLINE (via PubMed), EMBASE, LILACS, SciELO, Scopus, Cochrane Library and mRCT databases to identify clinical trials and observational studies that assessed the pharmacological treatment of the following groups of patients: pregnant women, nursing mothers, children, the elderly, individuals with chronic diseases and individuals with suppressed immune systems. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. The available evidence suggests that the treatments of choice for each population or disease entity are as follows: nursing mothers and children (meglumine antimoniate or pentamidine), patients with renal disease (amphotericin B or miltefosine), patients with heart disease (amphotericin B, miltefosine or pentamidine), immunosuppressed patients (liposomal amphotericin), the elderly (meglumine antimoniate), pregnant women (amphotericin B) and patients with liver disease (no evidence available). The quality of evidence is low or very low for all groups. Accurate controlled studies are required to fill in the gaps in evidence for treatment in special populations. Post-marketing surveillance programs could also collect relevant information to guide treatment decision-making
G6PD deficiency in Latin America: systematic review on prevalence and variants
Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that induces haemolysis in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals, which further hampers malaria control efforts. The aim of this work was to study the G6PDd prevalence and variants in Latin America (LA) and the Caribbean region. A systematic search of the published literature was undertaken in August 2013. Bibliographies of manuscripts were also searched and additional references were identified. Low prevalence rates of G6PDd were documented in Argentina, Bolivia, Mexico, Peru and Uruguay, but studies from Curaçao, Ecuador, Jamaica, Saint Lucia, Suriname and Trinidad, as well as some surveys carried out in areas of Brazil, Colombia and Cuba, have shown a high prevalence (> 10%) of G6PDd. The G6PD A-202A mutation was the variant most broadly distributed across LA and was identified in 81.1% of the deficient individuals surveyed. G6PDd is a frequent phenomenon in LA, although certain Amerindian populations may not be affected, suggesting that PQ could be safely used in these specific populations. Population-wide use of PQ as part of malaria elimination strategies in LA cannot be supported unless a rapid, accurate and field-deployable G6PDd diagnostic test is made available
Estudo da prevalência de fluorose dentária em Aracaju Study of the prevalence of dental fluorosis in Aracaju
Com o objetivo de determinar a prevalência de fluorose dentária em Aracaju (SE), 196 escolares foram submetidos a exame clínico bucal, utilizando o índice de Dean. Pôde ser concluído que a prevalência de fluorose dentária em escolares de cinco a quinze anos do município de Aracaju (SE) foi de 8,16%, não implicando risco à saúde pública. Porém, estudos semelhantes devem ser realizados com periodicidade regular, além de orientação aos órgãos responsáveis pela fluoretação da água, para que os níveis considerados ótimos para essa região sejam respeitados, prevenindo assim o surgimento de tal ocorrência.<br>With the aims of determining the prevalence dental fluorosis in the city of Aracaju, Sergipe State, 196 students were submitted to an oral exam, utilizing the Dean's index. It was concluded that the prevalence of dental fluorosis in students ranging from 5 to 15 years old in the city of Aracaju, Sergipe State was of 8.16%, not implying in a risk to public health. However, similar studies must be done regularly, besides orientation to governmental departments responsible for water fluoridation, so that the level considered excellent for this area can be respected, avoiding such problem to occur